SmartCAT Raises $2.8 Million in Seed Funding and Becomes

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SmartCAT Raises $2.8 Million in Seed Funding and Becomes Fully Independent From ABBYY

MILPITAS, CA--(Marketwired - Aug 9, 2016) - SmartCAT, the developer of the namesake cloud translation automation platform, which combines all the latest translation technologies aimed at lowering costs and increasing quality in one solution, with a global marketplace of over 60,000 translation professionals, today announced that it has raised a $2.8 million seed round from venture fund RedSeed.

The SmartCAT platform is designed to optimize translation processes while improving translation quality at the same time. SmartCAT's global translator marketplace allows customers to invite an unlimited number of translators, editors and managers to their projects, thus dramatically reducing the time needed for their completion.

SmartCAT's computer assisted translation (CAT) platform prevents the majority of human errors with the help of translation memories, glossaries, intelligent QA checks and innovative AI algorithms, thus increasing the overall quality of the final translation. All users, whether they are freelancers, translation agencies or any other companies in need of translation, have unlimited and free access to SmartCAT translation automation technologies. Customers have reported savings of up to 70% through the use of SmartCAT technologies.

More than 1,500 companies, including Weebly, Epicor, Coursera, Adherium, YIT, Netcracker, GSK, many language services providers and over 60,000 translators from 100 different countries are already using SmartCAT. Every month, users translate around 100 million words on the platform, a figure that continues to grow rapidly.

When it comes to project management, SmartCAT gives customers direct access to over 60,000 freelancers in a wide variety of language pairs and specializations. The platform provides project managers with tools and processes to quickly assemble project-specific teams, track progress and enable effective communication within the team. The latest addition -- now in beta testing -- is chatbots, which significantly reduce the time needed for executing analysis and reporting tasks.

Closing the circle, SmartCAT covers a translation project's financial workflow, acting as a hub between end-customers and all vendors and freelancers engaged in a project -- all at a disruptively low commission of 10%. This commission constitutes the platform's main source of revenue, along with the sale of on-premise solutions and additional services: expanded technical support, integration services, etc.

SmartCAT was initially developed by multinational AI software company ABBYY . In 2016, SmartCAT started its gradual spin-out process and became a fully independent company.

"Our management team has a strong track record in the translation industry, having grown several companies in the US and Europe from zero to hero," says SmartCAT founder and CEO Ivan Smolnikov. "We started SmartCAT because we believed that cloud technologies are a blessing for many professions, and that translation is no exception. By combining cutting-edge technology and a carefully garnered pool of translators, we've unlocked unique value for all market participants. Another unprecedented feature of SmartCAT is that it gives everyone -- from freelancers to translation vendors and end-customers -- the freedom to use state-of-the-art technology at absolutely no cost and without any limitations. We are proud to have a hand in fueling the business growth of our customers."

"We first heard about SmartCAT through one of our portfolio companies," says Ilya Shirokov, Founder and Managing Partner at RedSeed. "They were using SmartCAT to automate their translation processes and thus significantly reduced their operating costs. As we learned more about SmartCAT, we became impressed with the sophistication of their platform and the dedication of their team. SmartCAT is becoming an increasingly significant component of the $40 billion translation market."

About SmartCAT SmartCAT, headquartered in Milpitas, California, is the developer of the namesake translation automation platform ( www.SmartCAT.ai ), which streamlines cooperation between translators, translation agencies and all companies seeking to translate their content. SmartCAT gives everyone -- from freelancers to translation vendors and end customers -- the freedom to use state-of-the-art translation technologies at absolutely no cost and with no limitations. More than 1,500 companies, including Epicor, Weebly, Coursera, NetCracker, YIT, numerous translation agencies and over 60,000 translators in nearly 100 countries have taken advantage of SmartCAT technologies. At its core, SmartCAT is built upon the company's own patented inventions.

About RedSeed RedSeed is an investment firm focusing on technology and Internet companies. Ilya Shirokov founded RedSeed in 2015. Before this endeavor, Shirokov launched the first social network in Russia (now sold to Yandex), managed DST VC portfolio and served as the CEO of Odnoklassniki, one of Europe's largest Internet companies. RedSeed employs its unique operational experience to help portfolio companies scale their businesses into billion-dollar companies.

Contacts ABBYY USA Email Contact Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 185

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 170

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 234

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 155

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 143

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 249

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 230

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 313

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading

Top 5 Most Recently Viewed Articles

Healthcare Realty Trust's Q4 Highlights and Dividend Update

Updated Category News Views 112

Healthcare Realty Trust Quarterly Results Overview Healthcare Realty Trust Incorporated (NYSE: HR) has reported its fourth quarter results for the year 2024, highlighting significant developments in its operations and financial performance. The company recorded a net (loss) income attributable to common stockholders of $(106.8) million, or $(0.31) per diluted share,...

Continue Reading
BGL's Strategic Move: Selling Western Botanicals to Riverside

Updated Category News Views 322

Brown Gibbons Lang & Company (BGL) has just sealed the deal on a significant sale—Western Botanicals, a prominent player in the Vitamins, Minerals, and Supplements (VMS) contract development and manufacturing space, is headed to The Riverside Company. Now this isn’t just another corporate shuffle; it's BGL’s third foray into the CDMO subsector and marks their fourth...

Continue Reading
High Arctic Energy Services Reports Second Quarter 2025 Success

Updated Category News Views 225

High Arctic Energy Services Reports Strong Second Quarter Results High Arctic Energy Services Inc. (TSX: HWO), a noted energy services provider, has recently shared its financial results for the second quarter of 2025, highlighting a continued commitment to operational excellence amid challenging market conditions. 2025 Second Quarter Performance Overview The company...

Continue Reading
DXC Technology Investors Notified of Securities Class Action

Updated Category News Views 45

DXC Technology Class Action Notice for Shareholders The Gross Law Firm has released an important notice for shareholders of DXC Technology Company (NYSE: DXC). This notice is aimed at individuals who acquired shares during the specified class period. Shareholders are encouraged to reach out to the firm if they are interested in being considered for the role of lead...

Continue Reading
Manulife's $750M US Offering: Risky or Strategic?

Updated Category News Views 50

Manulife: Debuting $750M in Subordinated Notes When it comes to Manulife's latest move, it's all about the numbers. They've priced a U.S. public offering of a meaty $750 million in subordinated notes at an enticing 6.146% interest rate. That's no pocket change, folks, and it highlights a strategy or a gamble, depending on your view. But here's the kicker: these notes may...

Continue Reading